Lithium reduces pathological aggression and suicidality: A mini-review

Neuropsychobiology

Volumn 62, Issue 1, 2010, Pages 43-49

  Müller Oerlinghausen, Bruno ^a,c   Lewitzka, Ute ^b  

^a Drug Commission of the German Medical Association   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c NONE   (Germany)

Author keywords

Children; Lithium; Pathological aggression; Prisoners; Suicide; Suicide attempt

Indexed keywords

ANTICONVULSIVE AGENT; HALOPERIDOL; LITHIUM SALT; METHYLPHENIDATE; PLACEBO; PROPRANOLOL; SEROTONIN; SEROTONIN TRANSPORTER; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT;

AGGRESSION; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEHAVIOR DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; CONDUCT DISORDER; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MOOD DISORDER; MORTALITY; NAUSEA; NONHUMAN; POLYDIPSIA; POLYURIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RAGE; RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SHORT SURVEY; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY FREQUENCY; VOMITING; ANIMAL; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM;

AGGRESSION; ANIMALS; ANTIPSYCHOTIC AGENTS; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS; SUICIDE;

EID: 77951968835     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314309     Document Type: Short Survey

References (71)

1. Grof P, Müller-Oerlinghausen B: A critical appraisal of lithium's efficacy and effectiveness: the last 60 years. Bipolar Disord 2009; 11(Suppl 2):10-19.
2. Grof P: Sixty years of lithium responders. Neuropsychobiology 2010;62:8-16.
3. Bauer M, Grof P, Müller-Oerlinghausen B (eds): Lithium in Neuropsychiatry. London, Informa, 2006, pp 33-42.
4. Lundquist G: Prognosis and cause of manic depressive psychosis. Acta Psychiatr Neurol Scand 1945; 35: 1-96.
5. Petterson U: Manic-depressive illness: a clinical, social and genetic study. Acta Psychiatr Scand Suppl 1977; 269: 55-60.
6. Tsuang MT, Woolson RF: Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry 1978; 35: 1181-1185.
7. Weeke A: Causes of death in manic depressives; in Schou M, Strömgren E (eds): Origin, Prevention and Treatment of Affective Disorders. London, Academic Press, 1979, pp 289-299.
8. Hagnell O, Lanke J, Rorsman B: Suicide rates in the Lundby study: mental illness as a risk factor for suicide. Neuropsychobiology 1981; 7: 248-253.
9. Tuckman J, Youngman W: Identifying suicide with groups among attempted suicide. Public Health Rep 1963; 78: 763-766.
10. Motto I: Suicide attempts: a longitudinal view. Arch GenPsychiatry 1965; 13: 516-520.
11. Guze SB, Robins E: Suicide in primary affective disorders. Br J Psychiatry 1970; 117: 437-438.
12. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990.
13. Harris EC, Barraclough B: Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11-53.
14. Ahrens B, Müller-Oerlinghausen B, Schou M, et al: Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium-prophylaxis. J Affect Disord 1995; 33: 67-75.
15. Newman S, Bland R: Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand 1991; 83: 420-426.
16. Ösby U, Brandt L, Correia N, et al: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844-850.
17. Lester D: Suicidal behavior in bipolar and unipolar affective disorders: a meta-analysis. J Affect Disord 1993; 27: 117-121.
18. Angst J, Sellaro R, Angst F: Long-term outcome and mortality of treated vs untreated bipolar and depressed patients: a preliminary report. Int J Psychiatry Clin Pract 1998; 2: 115-119.
19. Bottlender R, Jager M, Strauss A, et al: Suicidality in bipolar compared to unipolar depressed inpatients. Eur Arch Psychiatry Clin Neurosci 2000; 250: 257-261.
20. Barraclough B: Suicide prevention, recurrent affective disorder and lithium. Br J Psychiatry 1972; 121: 91-392.
21. Müller-Oerlinghausen B, Müser-Causemann B, Volk J: Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992; 25: 261-270.
22. Felber W, Kyber A: Suizide und Parasuizide während und ausserhalb einer Lithiumprophylaxe; in Müller-Oerlinghausen B, Berghöfer A (eds): Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart, Thieme, 1994, pp 53-59.
23. Coppen A, Standish-Barry H, Bailey J, et al: Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991; 23: 1-7.
24. Müller-Oerlinghausen B, Ahrens B, Grof E, et al: The effect of long-term lithium treatment on the mortality of patients with manic- depressive and schizo-affective illness. Acta Psychiatr Scand 1992; 86: 218-222.
25. Coppen A: Depression as a lethal disease: prevention strategies. J Clin Psychiatry 1994; 55(suppl 4):37-45.
26. Müller-Oerlinghausen B, Wolf T, Ahrens B, et al: Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients. Acta Psychiatr Scand 1994; 90: 295-297.
27. Baldessarini RJ, Tondo L, Hennen J: Effects of lithium treatment and its discontinuation on suicidal behaviour in bipolar manic-depressive disorders. J Clin Psychiatry 1999; 60(suppl 2):77-84.
28. Baldessarini RJ, Tondo L, Hennen J: Effect of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999; 60(suppl 2):77-84.
29. Guzzetta F, Tondo L, Centorrino F, et al: Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007; 68: 380-383.
30. Kessing LV, Sondergard L, Kvist K, et al: Suicide risk in patients treated with lithium. Arch Gen Psychiatry 2005; 62: 860-866.
31. Cipriani A, Pretty H, Hawton K, et al: Lithium in the prevention of suicidal behavior and all-mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162: 1805-1819.
32. Lauterbach E, Felber W, Müller-Oerlinghausen B, et al: Adjunctive lithium treatment in the prevention of suicidal behavior in depressive disorders: a randomized, placebocontrolled 1 year trial. Acta Psychiatr Scand 2008; 118: 469-479.
33. Yerevanian BI, Kock RJ, Mintz J: Lithium, anticonvulsants and suicidal behaviour in bipolar disorder. J Affect Disord 2003; 73: 223-228.
34. Ahrens B, Müller-Oerlinghausen B: Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 2001; 34: 132-136. (Pubitemid 32701762)
35. Bierbrauer J, Nilsson A, Müller-Oerlinghausen B, et al: Therapeutic and prophylactic effects of lithium on pathological aggression; in Bauer M, Grof P, Müller-Oerlinghausen B (eds): Lithium in Neuropsychiatry. London, Informa, 2006, pp 227-236.
36. Goodwin FK: Anticonvulsant therapy and suicide in affective disorders. J Clin Psychiatry 1999; 60(suppl 2):89-93.
37. Thies-Fletchner K, Müller-Oerlinghausen B, Seibert W, et al: Effect of prophylactic treatment on suicide risk in patients with affective disorders: data from a randomized prospective study. Pharmacopsychiatry 1996; 29: 103-107.
38. Goodwin FK: Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry 2003; 64: 18-24.
39. Sondergard L, Lopez AG, Andersen PK, et al: Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008; 10: 87-94.
40. Collins JC, McFarland BH: Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008; 107: 23-28.
41. Joffe R: Does lithium save lives? J Psychiatry Neurosci 2004; 29: 9.
42. Licht RW, Vestergaard P, Brodersen A: Longterm outcome of patients with bipolar disorder commenced on lithium during hospitalization: a complete 15-year register-based follow-up. Bipolar Disord 2008; 10: 79-86.
43. Soares-Weiser K, Bravo Vergel V, Revnun S, et al: A systematic review and economic model of the clinical effectiveness and costeffectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 2007; 11: 206.
44. Cade JF: Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-352.
45. Forssman H, Walinder J: Lithium treatment of atypical indications. Acta Psychiatr Scand Suppl 1969; 207: 34-40.
46. Baastrup P: Practical clinical viewpoints regarding treatment with lithium. Acta Psychiatr Scand Suppl 1969; 207: 12-18.
47. Campbell M, Small AM, Green WH, et al: Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 1984; 41: 650-656.
48. Campbell M, Adams PB, Small AM, et al: Lithium in hospitalized children with conduct disorder: a double-blind and placebo controlled study. J Am Acad Child Adolesc Psychiatry 1995; 34: 445-453.
49. Rifkin A, Karajgi B, Dicker R, et al: Lithium treatment of conduct disorders in adolescents. Am J Psychiatry 1997; 154: 554-555.
50. Malone RP, Bennett DS, Luebbert JF, et al: Aggression classification and treatment response. Psychopharmacol Bull 1998; 34: 41-45.
51. Carlson GA, Rapport MD, Pataki CS, et al: Lithium in hospitalized children at 4 and 8 weeks: mood, behavior and cognitive effects. J Child Psychol Psychiatry 1992; 33: 411-425.
52. Malone RP, Delaney MA, Luebbert JF, et al: A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 2000; 57: 649-654.
53. Dostal T, Zvolsky P: Antiaggressive effect of lithium salts in severe mentally retarded adolescents. Int Pharmacopsychiatry 1970; 5: 203-207.
54. Micev V, Lynch DM: Effect of lithium on disturbed severely mentally retarded patients. Br J Psychiatry 1974; 125: 111.
55. Luchins DJ, Dojka D: Lithium and propanolol in aggression and self-injurious behaviour in the mentally retarded. Psychopharmacol Bull 1989; 25: 372-375.
56. Glenn MB, Wroblewski B, Parziale J, et al: Lithium carbonate for aggressive behaviour or affective instability in ten brain-injured patients. Am J Phys Med Rehabil 1989; 68: 221-226.
57. Bellus SB, Stewart D, Vergo JG, et al: The use of lithium in the treatment of aggressive behaviours with two brain-injured individuals in a state psychiatric hospital. Brain Inj 1996; 10: 849-860.
58. Van Putten T, Sanders DG: Lithium in treatment failures. J Nerv Ment Dis 1975; 161: 255-264.
59. Rifkin A, Quitkin F, Carrillo C, et al: Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry 1972; 27: 519-524.
60. Prado-Lima P, Knijnik L, Juruena M, et al: Lithium reduces maternal child abuse behavior: a preliminary report. J Clin Pharm Ther 2001; 26: 279-282.
61. Dorrego MF, Canevaro L, Kuzis G, et al: A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 2002; 14: 289-295.
62. Sheard MH: Effect of lithium in human aggression. Nature 1971; 230: 113-114.
63. Tupin JP, Smith DB, Clanon TL, et al: The long-term use of lithium in aggressive prisoners. Compr Psychiatry 1973; 14: 311-317.
64. Sheard MH: Lithium in the treatment of aggression. J Nerv Ment Dis 1975; 160: 108-118.
65. Sheard MH, Marini JL, Bridges CI, et al: The effect of lithium on impulsive aggressive behaviour in man. Am J Psychiatry 1976; 133: 1409-1413.
66. McElroy SL, Pope HG Jr, Keck PE Jr, et al: Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996; 37: 229-240.
67. Müller-Oerlinghausen B: Lithium long-term treatment - does it act via serotonin? Pharmacopsychiatry 1985; 18: 214-217.
68. Coccaro EF: Central serotonin and impulsive aggression. Br J Psychiatry 1989; 8(suppl): 52-62.
69. Coccaro EF, Siever LJ, Klar HM, et al: Serotonergic studies in affective and personality disorder patients; correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46: 587-599.
70. Coccaro EF, Kavoussi RJ, Sheline YI, et al: Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 1996; 53: 531-536.
71. Roggenbach J, Müller-Oerlinghausen B, Franke L, et al: Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. J Neural Transm 2007; 114: 479-1478